Raia Drogasil S.A. (OTCMKTS:RADLY – Get Free Report) was the recipient of a significant growth in short interest in December. As of December 15th, there was short interest totaling 40,911 shares, a growth of 1,671.0% from the November 30th total of 2,310 shares. Based on an average daily trading volume, of 38,655 shares, the short-interest ratio is presently 1.1 days. Based on an average daily trading volume, of 38,655 shares, the short-interest ratio is presently 1.1 days.
Raia Drogasil Trading Up 2.9%
RADLY traded up $0.13 on Wednesday, hitting $4.72. 1,658 shares of the company’s stock were exchanged, compared to its average volume of 20,365. Raia Drogasil has a fifty-two week low of $2.17 and a fifty-two week high of $4.85. The firm has a 50-day moving average price of $4.13 and a 200-day moving average price of $3.44.
Raia Drogasil Company Profile
Raia Drogasil SA is a leading Brazilian retail pharmacy operator, offering a comprehensive range of prescription and over-the-counter medications, health and wellness products, personal care and beauty items, as well as a selection of convenience goods. The company’s network of stores operates under the Raia and Drogasil banners, serving diverse consumer needs across major urban centers. Complementary services include in-store prescription dispensing, compounding pharmacies and health screening programs such as blood pressure and glucose monitoring.
The company was formed in 2011 through the merger of two established Brazilian pharmacy chains, Drogasil and Droga Raia, each with origins dating back several decades.
Read More
- Five stocks we like better than Raia Drogasil
- How Long Will $1M Last in Retirement?
- Washington prepares for war
- A month before the crash
- The boring AI play that could pay up to $4,290 monthly
- The Best $1 You’ll Spend This Holiday Season
Receive News & Ratings for Raia Drogasil Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Raia Drogasil and related companies with MarketBeat.com's FREE daily email newsletter.
